What to Expect From Your Eligibility Check

The eligibility check is the first step in understanding whether home-based pembrolizumab could be right for you. It takes about three minutes, and every response is reviewed by a qualified oncologist within 24 hours. Here is exactly what to expect, from starting the form to receiving a response.

What the questionnaire asks

The questionnaire is designed to gather the clinical information an oncologist needs to make a meaningful preliminary assessment. You will be asked about:

• Your cancer type and current stage
• Your PD-L1 expression result (TPS or CPS score, if you have it)
• Your current or most recent treatment, and how you responded
• Any relevant health conditions, particularly those that might affect immunotherapy suitability
• Your current performance status and day-to-day function
• Basic contact details to allow the team to follow up

You do not need to have all of this information to hand before starting. You can save your progress and return to it. If you are missing a result - for example, you know you have had a PD-L1 test but do not have the number - note this in the form and an oncologist will advise on next steps.

What happens when you submit

Once you submit, your responses are reviewed by a qualified oncologist - not a screening algorithm. The oncologist considers whether, based on the information provided, pembrolizumab at home could be a clinically appropriate option. They look at cancer type, treatment history, biomarker results, and clinical context.

You will receive a response within 24 hours - typically much sooner. The response will either indicate that you could be a suitable candidate and outline the next step (a free Welcome Call), or explain clearly why the service may not be the right fit and suggest alternatives.

What the response means

A positive preliminary assessment is not a treatment decision. It means an oncologist believes, on the basis of the information provided, that a more thorough assessment is worthwhile. The Welcome Call that follows is where the clinical team can explore your situation in more detail, answer your questions, and give you a clearer picture of what treatment would involve.

If the assessment suggests pembrolizumab at home is not the right option for you, the oncologist will explain why. This might be because your cancer type is not currently covered, your biomarker results do not meet the eligibility threshold, or another aspect of your health requires a different approach. In every case, you will receive a clear, honest explanation.

There is no obligation to proceed

Completing the eligibility check commits you to nothing. It is simply a way to find out whether this service could be appropriate for your situation - free of charge, with a response from a real oncologist within 24 hours. You can decide what to do with that information entirely on your own terms.